Public offerings often result in short-term negative sentiment due to the potential for dilution of existing shares. However, the capital raised can be very beneficial for the company's long-term growth and financial health. The impact on ICHR's stock price in the short term could be neutral to slightly negative, depending on investor perception of the company's growth prospects and use of the raised capital.